What is Carenostics?
Founded in 2021, Carenostics operates at the intersection of healthcare technology and clinical decision support. The company provides a sophisticated platform that integrates seamlessly with existing electronic health records to identify and manage chronic conditions more effectively. By automating the detection of at-risk patients, Carenostics enables providers to deliver proactive care, thereby reducing the burden on hospital systems and improving the quality of life for patients. Its market position is defined by its focus on actionable intelligence, moving beyond simple data aggregation to provide clinicians with the tools necessary for precise, timely interventions in complex chronic disease management.
How much funding has Carenostics raised?
Carenostics has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2023): $5M with participation from Gaingels, M13, and GreatPoint Ventures
Key Investors in Carenostics
Gaingels
Gaingels is a prominent investment syndicate dedicated to supporting the LGBTQ community and allies, providing capital to high-growth companies across various sectors including healthcare and B2B technology.
M13
M13 is an early-stage venture capital firm comprised of full-time operators who specialize in helping founders scale their businesses and build category-defining software companies.
GreatPoint Ventures
GreatPoint Ventures is a San Francisco-based firm founded by experienced entrepreneurs that provides both capital and operational expertise to help early-stage companies achieve significant enterprise value.
What's next for Carenostics?
With this major strategic investment, Carenostics is poised to deepen its market penetration and broaden its technological footprint. The company is expected to prioritize the scaling of its enterprise-grade infrastructure, ensuring that its platform can support the rigorous demands of large-scale health systems. Future growth initiatives will likely focus on expanding the platform's diagnostic capabilities and strengthening its integration ecosystem. As the healthcare industry continues to shift toward value-based care models, Carenostics is well-positioned to capitalize on the increasing demand for digital solutions that drive operational efficiency and superior clinical results. The firm's roadmap suggests a focus on sustainable growth, strategic partnerships, and the continued refinement of its predictive analytics engine to maintain its competitive edge in the health-tech sector.
See full Carenostics company page
